Roles of proinflammatory and anti-inflammatory cytokines in pathophysiology of bacterial meningitis and effect of adjunctive therapy

Infection and Immunity

Volumn 64, Issue 12, 1996, Pages 4883-4890

  Van Furth, A Marceline ^a   Roord, John J ^a   Van Furth, Ralph ^b,c  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c NONE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CEFOTAXIME; CEFTRIAXONE; CEFUROXIME; CHLORAMPHENICOL; CYTOKINE; DEXAMETHASONE; GLUCOCORTICOID; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; LISOFYLLINE; METHYLPREDNISOLONE; METHYLXANTHINE DERIVATIVE; MONOCLONAL ANTIBODY; NITRIC OXIDE; PENICILLIN G; PENTOXIFYLLINE; PROSTAGLANDIN; SULBACTAM; SULFADIAZINE; THALIDOMIDE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

B LYMPHOCYTE; BACTERIAL CELL WALL; BACTERIAL MENINGITIS; BLOOD BRAIN BARRIER; DRUG MECHANISM; DRUG MIXTURE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; INFLAMMATION; INTRACEREBRAL DRUG ADMINISTRATION; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; T LYMPHOCYTE;

EID: 0029849195     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.12.4883-4890.1996     Document Type: Short Survey

References (168)

1. Andersson, P. B., V. H. Perry, and S. Gordon. 1942. Intracerebral injection of proinflammutory cytokines or leukocyte chemotaxins induces minimal myelomonocytic cell recruitment to the parenchyma of the central nervous system. J. Exp. Med. 176:255-259.
2. Arditi, M., L. Ables, and R. Yogev. 1989. Cerebrospinal fluid endoloxin levels in children with H. influenzae meningitis before and after administration of intravenous ceftriaxone. J. Infect, Dis. 160:1005-1011.
3. Arditi, M., W. Kabat, and R. Yogev. 1993. Antibiotic-induced bacterial killing stimulates tumor necrosis factor-alpha release in whole blood. J. Infect. Dis. 167:240-244.
4. Arditi, M., K. R. Manogue, M. Caplan, and R. Yogev. 1990. Cerebrospinal fluid cachectin/lumor necrosis factor-alpha and platelet-activating factor concentrations and severity of bacterial meningitis in children. J. Infect. Dis. 162:139-147.
5. Baggiolini, M., B. Dewald, and B. Moser. 1994. Interleukin-8 and related chemotactic cytokincs - CXC and CC chemokines, Adv. Immunol. 55:97-179.
6. Baggiolini, M., A. Walz, and S. L. Kunkel. 1989. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J. Clin. Invest. 84:1045-1049.
7. Barnes, P. J., and S. Pedersen. 1993. Efficacy and safety of inhaled corti- costeroids in asthma. Report of a workshop held in Eze, France, October 1992. Am. Rev. Respir. Dis. 148:S1-S26.
8. Beekhuizen, H., A. J. Corsel-Van Tilburg, I. Blokland, and R. Van Furth. 1991. Characterization of the adherence of human monocytes to cylokine- stimulated human macrovascular endnthelial cells. Immunology 74:661-669.
9. Belsey, M. A., C. W. Hoffpauir, and M. H. D. Smith. 1969. Dexamethasone in the treatment of acute bacterial meningitis: the effect of study design on the interpretation of results. Pediatrics 44:503-513.
10. Bessler, H., R. Gilgal, M. Djaldetti, and I. Zahavi, 1986. Effect of pentoxifylline on the phagocytic activity, cAMP levels, and Superoxide anion production by monocytes and polymorphonuclear cells. J. Leukocyte Biol. 40:747-754.
11. Beutler, B., and A. Cerami. 1987. Cachetin: more than a tumor necrosis factor. (Review,) N. Engl. J. Med, 316:379-385.
12. Bruyn, G. A., H. P. Kremer, S. de Marie, G. W. Padberg, J. Hermans, and R. Van Furth. 1989. Clinical evaluation of pneumococcal meningitis in adults over a twelve-year period. Eur. J. Clin. Microbiol. Infect. Dis. 8:695-700.
13. Burroughs, M., C. Cabellos, S. Prasad, and E. Tuomanen. 1992. Bacterial components and the pathophysiology of injury to the blood-brain barrier: does cell wall add to the effects of endotoxin in gram-negative meningitis? J. Infect. Dis. l65(Suppl. 1):S82-S85.
14. Burroughs, M., S. Prasad, C. Cabellos, P. M. Mendelman, and E. Tuomanen. 1993. The biologic activities of peptidoglycan in experimental Haemophilus influenzae meningitis. J. Infect. Dis. 167:464-468.
15. Bursten, S., R. Weeks, J. West, T. Le, T. Wilson, D. Porunek, J. A. Blanco, J. W. Singer, and G. C. Rice. 1994. Potential role for phosphatidic acid in mediating the inflammatory responses to TNF alpha and IL-1 beta. Circ. Shock 44:14-29.
16. Chantry, D., M. Turner, E. Abney, and M. Feldmann. I989. Modulation of cytokine production by transforming growth factor-β. J. Immunol. 142: 4295-4300.
17. Chao, C. C., S. Hu, K. Close, C. S. Choi, T. W. Molitor, W. J. Novick, and P. K. Peterson. 1992. Cytokine release from microglia: differential inhibition by pentoxifylline and dexamethasone. J. Infect. Dis, 166:847-853.
18. Dawson, T. M., V. L. Dawson, and S. H. Snyder. 1992. A novel neuronal messenger molecule in brain the free radical, nitric oxide, Ann. Neurol. 32:297-311.
19. deLemos, R. A., and R. J. Haggerty. 1969. Corticosteroids us an adjunct to treatment in bacteria meningitis. A controlled clinical trial. Pediatrics 44: 30-34.
20. de Waal Malefyt, R., J. Abrams, B. Bennett, C. G. Figdor, and J. E. de Vries. 1991. Interleukin 10 (IL-10) inhibits cytokine synthesis by human mono- cytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174:1209-1220.
21. Dinarello, C. A. 1988. Biology of interleukin 1. FASEB J. 2:108-115.
22. Dinarello, C. A. 1996. Biological basis for interleukin-1 in disease. Blood 87:2095-2147.
23. 3 inhibit induction of macrophage nitrogen oxide synthesis by IFN. J. Immunol. 145:940-944.
24. Dulkerian, S. J., L. Kilpatrick, A. T. Costarino, L. McCawley, J. Fein, L. Corcoran, S. Zirin, and M. C. Harris. 1995. Cytokine elevations in infants with bacterial and aseptic meningitis. J. Pediatr. 126:872-876.
25. Endres, S. 1993. Messengers and mediators: interactions among lipids, eicosanoids, and cytokines. Am. J. Clin. Nutr. 57:798S-800S.
26. Endres, S., H. J. Fulle, B. Sinha, D. Stoll, C. A. Dinarello, R. Gerer, and P. C. Weber. 1991. Cyclic nucleotides differentially regulate the synthesis of tumour necrosis factor-alpha and interleukin-1 beta by human mononuclear cells. Immunology 72:56-60.
27. Frei, K., D. Nadal, H. W. Pfister, and A. Fontana. 1993. Listeria meningitis: identification of a cerebrospinal fluid inhibitor of macrophage listericidal function us interleukin 10. J. Exp. Med. 178:1255-1261.
28. Friedland, I. R., H. Jafari, S. Ehrett, S. Rinderknecht, M. Paris, M. Coulthard, H. Saxen, K. Olsen, and G. H. McCracken, Jr. 1993. Comparison of endotoxin release by different antimicrobial agents and the effect on inflammation in experimental Escherichia coli meningitis. J. Infect. Dis. 168:657-662.
29. Friedland, I. R., M. M. Paris, S. Hickey, S. Shelton, K. Olsen, J. C. Paton, and G. H. McCracken. 1995. The limited role of pneumolysin in the pathogenesis of pneumococcal meningitis. J. Infect. Dis. 172:805-809.
30. Gerard, C., C. Bruyns, A. Marchant, D. Abramowicz, P. Vandenabeele, A. Delvaux, W. Fiers, M. Goldman, and T. Velu. 1993. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J. Exp. Med. 177:547-550.
31. Girgis, N. I., Z. Farid, I. A. Mikhall, I. Farrag, Y. Sultan, and M. E. Kilpatrick. 1989. Dexamethasone treatment for bacterial meningitis in children and adults. Pediatr. Infect. Dis. J. 8:848-851.
32. Glimaker, M., P. Kragsbjerg, M. Forsgren, and P. Olcen. 1993. Tumor necrosis factor-alpha (TNF alpha) in cerebrospinal fluid from patients with meningitis of different etiologies: high levels of TNF alpha indicate bacterial meningitis. J. Infect. Dis. 167:882-889.
33. Guerra-Romero, L., J. H. Tureen, and M. G. Tauber. 1992. Pathogenesis of central nervous system injury in bacterial meningitis. Antibiot. Chemother. 45:18-29.
34. Halstensen, A., M. Ceska, P. Brandtzaeg, H. Redl, A. Naess, and A. Waage. 1993. Interleukin-8 in serum and cerebrospinal fluid from patients with meningococcal disease. J. Infect. Dis. 167:471-475.
35. Han, J., P. Thompson, and B. Beutler. 1990. Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway. J. Exp. Med. 172:391-394.
36. Helfgott, D. C., S. B. Tatter, U. Santhanam, R. H. Clarick, N. Bhardwaj, L. T. May, and P. B. Sehgal. 1989. Multiple forms of IFN-beta 2/IL-6 in serum and body fluids during acute bacterial infection. J. Immunol. 142: 948-953.
37. Henderson, B., and M. Wilson. 1996. Cytokine induction by bacteria: beyond lipopolysaccharide. Cytokine 8:269-282.
38. Heumann, D., C. Barras, A. Severin, M. P. Glauser, and A. Tomasi. 1994. Gram-positive cell walls stimulate synthesis of tumor necrosis factor alpha and interleukin-6 by human monocyles. Infect. Immun. 62:2715-2721.
39. Hu, S., A. Martella, W. R. Anderten, and C. C. Chao. 1994. Role of cytokines in lipopolysaccharide-induced functional and structural abnormalities of astrocytcs. Glia 10:227-234.
40. Huber, A. R., S. L. Kunkel, R. F. Todd III, and S. J. Weiss. 1991. Regulation of transendothelial neutrophil migration by endogenous interleukin-8. Science 254:99-102.
41. Ikejima, T., S. Okusawa, P. Ghezzi, J. W. van der Meer, and C. A. Dinarello. 1990. Interleukin-1 induces tumor necrosis factor (TNF) in human peripheral blood mononuclear cells in vitro and a circulating TNF-like activity in rabbits. J. Infect. Dis. 162:215-223.
42. Kadurugamuwa, J. L., B. Hengstler, and O. Zak. 1989. Cerebrospinal fluid protein profile in experimental pneumococcal meningitis and its alteration by ampicillin and anti-inflammatory agents. J. Infect. Dis. 159:26-34.
43. Kanra, G. Y., H. Ozen, G. Secmeer, M. Ceyhan, Z. Ecevit, and E. Belgin. 1995. Beneficial effects of dexamethasone in children with pneumococcal meningitis. Pediatr. Infect. Dis. J. 14:490-502.
44. 43a. Kaplan, C. Personal communication.
45. Kasama, T., R. M. Stricter, N. W. Lukacs, M. D. Burdick, and S. L. Kunkel. 1994. Regulation of neutrophil-derived chemokine expression by IL-10. J. Immunol. 152:3559-3569.
46. Kern, J. A., R. J. Lamb, J. C. Reed, R. P. Danleie, and P. C. Novell. 1988. Dexamethasone inhibition of interleukin 1 beta production by human monocytes. Posttranscriptional mechanisms. J. Clin. Invest, 81:237-244.
47. Kilbourn, R. G., and P. Belloni. 1990. Endothelial cell production of nitro- gen oxides in response to Interferon gamma in combination with tumor necrosis factor, interleukin-1, or endotoxin. J. Natl. Cancer Inst. 82:772-776.
48. Kllpi, T., H. Peltola, T. Jauhlainen, M. J. T. Kallio, and Finnish Study Group. 1995. Oral glycerol and intravenous dexamethasone in preventing neurological and audiological sequelae of childhood bacterial meningitis. Pediatr. Infect, Dis. J. 14:270-278.
49. King, S. M., B. Law, J. M. Langley, H. Heurter, D. Bremner, E. E. Wang, and R. Gold. 1994. Dexamethasone therapy for bacterial meningitis: better never than late? Can. J. Infect. Dis. 5:210-215.
50. Kornelisse, K. K., H. F. J. Savelkoul, P. H. G. Mulder, M. H. Suur, P. J. C. Van der Straaten, A. J. Van der Heijden, R. N. Sukhal, K. Kahlen, H. J. Neljens, and R. De Groot. 1996. Interleukin-10 and soluble tumor necrosis receptors in cerebrospinal fluid of children with bacterial meningtis. J. Infect. Dis. 173:1498-1502.
51. Kurose, I., P. Kubes, R. Wolf, D. C. Anderson, J. Paulson, M. Mlyasaka, and D. N. Granger. 1993. Inhibition of nitric oxide production. Mechanisms of vascular albumin leakage. Circ. Res. 73:164-171.
52. Lamas, S., T. Michel, B. M. Brenner, and P. A. Marsden. 1991. Nitric oxide synthesis in enduthelial cells: evidence for a pathway inducible by TNF-alpha. Am. J. Physiol. 261:C634-C641.
53. Lebel, M. H., B. J. Freij, G. A. Syrogiannopoulos, D. F. Chrane, M. J. Hoyt, S. M. Stewart, B. D. Kennard, K. D. Olsen, and G. H. McCracken, Jr. 1988. Dexamethasone therapy for bacterial meningitis. Results of two doubleblind, placebo-controlled trials. N. Engl. J. Med. 319:964-971.
54. Lebel, M. H., M. J. Hoyt, D. C. Waagner, N. K. Rollins, T. Finltzo, and G. H. McCracken. 1989. Magnetic resonance imaging and dexamethasone therapy for bacterial meningitis. Am. J. Dis. Child. 143:301-306.
55. Lee, S. C., D. W. Dickson, C. F. Brosnan, and A. Casadevall. 1994. Human astrocytes inhibit Cryptococcus neoformans growth by a nitric oxide-mediuled mechanism. J. Exp. Med. 180:365-369.
56. Lehmann, A. K., A. Halstensen, S. Sornes, O. Rokke, and A. Waage. 1995. High levels of interleukin 10 in scrum are associated with fatality in meningococcal disease. Infect. Immun. 63:2109-2112.
57. Leist, T. P., K. Frei, S. Kam-Hansen, R. M. Zinkernagel, and A. Fontana. 1988. Tumor necrosis factor alpha in cerebrospinal fluid during bacterial, but not viral, meningitis. Evaluation in murine model infections and in patients. J. Exp. Med. 167:1743-1748.
58. Lesse, A. J., E. R. Moxon, A. Zwahlen, and W. M. Scheld. 1988. Role of cerebrospinal fluid pleocytosis and Haemophilus influenzae type b capsule on blood brain barrier permeability during experimental meningitis in the rat. J. Clin, Invest. 82:102-109.
59. Lopez-Cortes, L. F., M. Cruz-Ruiz, J. Gomez-Mateos, D. Jimenez-Hernandez, J. Palomino, and E. Jimenez. 1993. Measurement of levels of tumor necrosis factor-alpha and interleukin-1 beta in the CSF of patients with meningitis of different etiologies: utility in the differential diagnosis. Clin. Infect. Dis. 16:534-539.
60. Lopez-Cortes, L. F., M. Cruz-Ruiz, J. Gomez-Mateos, P. Viciana-Fernandez, F. J. Martinez-Marcos, and J. Pachon, 1995. Interleukin-8 in cerebrospinal fluid from patients with meningitis of different etiologies: its possible role as neutrophil chemotactic factor. J. Infect. Dis. 172:581-584.
61. Lorenzl, S., U. Koedel, U. Dimagl, G. Ruckdeschel, and H. W. Pflster. 1993. Imaging of leukocyte-endothelium interaction using in vivo confocal laser scanning microscopy during the early phase of experimental pneumococcal meningitis. J. Infect. Dis. 168:927-933.
62. Marchant, A., C. Bruyns, P. Vandenabeele, U. Abramowicz, C. Gerard, A. Delvaux, P. Ghezzi, T. Velu, and M. Goldman. 1994. The protective role of interleukin-10 in endotoxin shock. Prog. Clin. Biol. Res. 388:417-423.
63. Marchant, A., C. Bruyns, P. Vandenabeele, M. Ducarme, C. Gerard, A. Delvaux, D. De Groote, D. Abramowlcz, T. Velu, and M. Goldman. 1994. lnterleukin-10 controls interferon-gamma and tumor necrosis factor production during experimental endotoxemia. Eur. J. Immunol. 24:1167-1171.
64. Marchant, A., J. Devlere, B. Byl, D. De Groote, J. L. Vincent, and M. Goldman. 1994. Interleukin-10 production during septicaemia. Lancet 343: 707-708.
65. M. Martich, G. D., R. L. Danner, M. Ceska, and A. F. Suffredini. 1991. Detection of interleukin 8 and tumor necrosis factor in normal humans after intravenous endotoxin: the effect of antiinflammatory agents. J. Exp. Med. 173:1021-1024.
66. Mastroianni, C. M., F. Paoletti, R. M. Rlvosecchi, L. Lancelia, F. Ticca, V. Vullo, and S. Delia. 1994. Cerebrospinal fluid interleukin 8 in children with purulent bacterial and tuberculous meningitis. Pediatr. Infect. Dis. J. 13: 1008-1010.
67. McCracken, G. H., Jr., M. M. Mustafa, O. Ramilo, K. D. Olsen, and R. C. Risser. 1989. Cerebrospinal fluid interleukin 1-heta and tumor necrosis factor concentrations and outcome from neonatal gram-negative enteric bacillary meningitis. Pediatr. Infect. Dis. J. 8:155-159.
68. Mertsola, J., W. A. Kennedy, D. Waagner, X. Saez-Liorens, K. Olsen, E. J. Hansen, and G. H. McCracken, Jr. 1991. Endotoxin concentrations in cerebrospinal fluid correlate with clinical severity and neurologic outcome of Haemophilus influenzae type B meningitis. Am. J. Dis. Child. 145:1094-1103.
69. Mertsola, J., O. Ramilo, M. M. Mustafa, X. Saez-Llorens, E. J. Hansen, and G. H. McCracken, Jr. 1989. Release of endotoxin after antibiotic treatment of Gram-negative bacterial meningitis. Pediatr. Infect. Dis. J. 8:904-906.
70. Mizuno, T., M. Sawada, T. Marunouchi, and A. Suzumura. 1994. Production of interleukin-10 by mouse glial cells in culture. Biochem. Biophys. Res. Commun. 205:1907-1915.
71. Moncada, S., R. M. Palmer, and E. A. Higgs. 1991. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43:109-142.
72. Moore, K. W., A. O'Garra, R. de Waal Malefyl. P. Vieira, and T. R. Mosmann. 1993. Interleukin-10. Annu. Rev. Immunol. 11:165-190.
73. Musso, T., I. Espinoza-Delgado, K. Pulkki, G. L. Gusella, D. L. Longo, and L. Varesio, 1990. Transforming growth factor β downregulates interleukin-1 (IL-1 )-induced IL-6 production by human monocytes. Blood 76:2466-2469.
74. Mustafa, M. M., M. H. Lebel, O. Ramilo, K. D. Olsen, J. S. Reisch, B. Beutler, and G. H. McCracken, Jr. 1989. Correction of interlcukin-l beta and cachectin concentrations in cerebrospinal fluid and outcome from bacterial meningitis. J. Pediatr. 115:208-213.
75. Mustafa, M. M., J. Mertsola, O. Ramilo, X. Saez-Llorens, R. C. Risser, and G. H. McCracken, Jr. 1989. Increased endotoxin and interleukin-l beta concentrations in cerebrospinal fluid of infants with coliform meningitis and ventriculilis associated with intraventricular gentamicin therapy. J. Infect. Dis. 160:891-895.
76. Mustafa, M. M., O. Ramilo, J. Mertsola, R. C. Kisser, B. Beutler, E. J. Hansen, and G. H. McCracken, Jr. 1989. Modulation of inflammation and cachectin activity in relation to treatment of experimental Haemophilus influenzae type b meningitis. J. Infect. Dis. 160:818-825.
77. Mustafa, M. M., O. Ramilo, K. D. Olsen, P. S. Franklin, E. J. Hansen, B. Beutler, and G. H. McCracken, Jr. 1989. Tumor necrosis factor in mediating experimental Haemophilus influenzae type B meningitis. J. Clin. Invest. 84:1253-1259.
78. Mustafa, M. M., O. Ramilo, X. Saez-Llorens, J. Mertsola, R. R. Magness, and G. H. McCracken, Jr. 1989. Prostaglandins E2 and I2, interleukin 1-beta, and tumor necrosis factor in cerebrospinal fluid in infants and children with bacterial meningitis. Pediatr. Infect. Dis. J. 8:921-922.
79. Mustafa, M. M., O. Ramilo, X. Saez-Llorens, J. Mertsola, and G. H. McCracken, Jr. 1989. Role of tumor necrosis factor alpha (cachectin) in experimental and clinical bacterial meningitis. Pediatr. Infect. Dis. J. 8:907-908.
80. Mustafa, M. M., O. Ramilo, X. Saez-Llorens, K. D. Olsen, R. R. Magness, and G. H. McCracken, Jr. 1990. Cerebrospinal fluid prostaglandins, interleukin 1 beta, and tumor necrosis factor in bacterial meningitis. Clinical and laboratory correlations in placebo-treated and dexamethasone-trealed patients. Am. J. Dis. Child. 144:883-887.
81. Nadal, D., D. Leppert, K. Frei, P. Gallo, H. Lamche, and A. Fontana. 1989. Tumour necrosis factor-alpha in infectious meningitis. Arch. Dis. Child. 64:1274-1279.
82. Neuner, P., G. Klosner, E. Schauer, M. Pourmojib, W. Macheiner, C. Grunwald, R. Knobler, A. Schwarz, T. A. Luger, and T. Schwarz. 1994. Pentoxifylline in vivo down-regulates the release of IL-1 beta, IL-6, IL-8 and tumour necrosis factor-alpha by human peripheral blood mononuclear cells. Immunology 83:262-267.
83. Nlu, X. F., C. W. Smith, and P. Kubes. 1994. Intracellular oxidative stress induced by nitric oxide synthesis inhibition increases endothelial cell adhesion to neutrophils. Circ. Res. 74:1133-1140.
84. Nowicki, J. P., D. Duval, H. Poignet, and B. Scatton. 1991. Nitric oxide mediates neuronal death after focal ischemia in the mouse. Eur. J. Pharmacol. 204:339-340.
85. Odio, C. M., I. Faingezicht, M. Paris, M. Nassar, A. Baltodano, J. Rogers, X. Saez-Llorens, K. D. Olsen, and G. H. McCracken, Jr. 1991. The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis. N. Engl. J. Med. 324:1525-1531.
86. Ohga, S., T. Aoki, K. Okada, H. Akeda, K. Fujloka, A. Ohshima, T. Mori, I. Minamishima, and K. Ueda. 1994. Cerebrospinal fluid concentration of interleukin-1 beta, tumor necrosis factor-alpha, and interferon gamma in bacterial meningitis. Arch. Dis. Child. 70:123-125.
87. Ossege, L. M., B. Voss, T. Wiethege, E. Sindem, and J. P. Malin. 1994. Detection of transforming growth factor beta 1 mRNA in cerebrospinal fluid cells of patients with meningitis by non-radioactive in situ hybridization. J. Neurol. 242:14-19.
88. Paris, M. M., I. R. Friedland, S. Ehrett, S. M. Hickey, K. D. Olsen, E. Hansen, E. J. Thonar, and G. H. McCracken, Jr. 1995. Effect of interlcukin-1 receptor antagonist and soluble tumor necrosis factor receptor in animal models of infection. J. Infect. Dis. 171:161-169.
89. Paris, M. M., S. Hickey, M. Trujillo, A. Ahmed, K. Olsen, and G. H. McCracken. 1995. Effect of interleukin-10(IL-10) in experimental bacterial meningitis, abstr. B22, p. 30 Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
90. Patrick, D., J. Betts, E. A. Frey, R. Prameya, K. Dorovini-Zis, and B. B. Finlay. 1992. Haemophilus influenzae lipopolysaccharide disrupts confluent monolayers of bovine brain endothelial cells via a serum-dependent cyto- toxic pathway. J. Infect. Dis. 165:865-872.
91. 89a. Peltola, H., T. Kipli, and M. Antilla. 1992. Rapid disappearance of Haemophilus influenzae type b meningitis after routine childhood immunisation with conjugate vaccines. Lancet 340:592-594.
92. Pfister, H. W., A. Fontana, M. G. Tauber, A. Tomasz, and W. M. Scheid. 1994. Mechanisms of brain injury in bacterial meningitis. Clin. Infect. Dis. 19:463-479.
93. 2 inhibits cerehrovascular changes and brain edema formation in the tumor necrosis faclor-α independent early phase of experimental pneumococeal meningitis. J. Exp. Med. 176:265-268.
94. Pomeroy, S. L., S. J. Holmes, P. R. Dodge, and R. D. Feigin. 1990. Seizures and other neurologic sequelae of bacterial meningitis in children. N. Engl. J. Med. 323:1651-1657.
95. Prasadaran, N. V., C. A. Wass, and K. W. Kim. 1996. Endothelial cell GLcNAcβ1-4GlcNAc epitopes for outer membrane protein A enhance traversal of Escherichia coli across the blood-brain barrier. Infect. Immun. 64:154-160.
96. Prasadarao, N. V., C. A. Wass, J. N. Weiser, M. F. Stins, S. H. Huang, and K. S. Kim. 1996. Outer membrane protein A of Escherichia coli contributes to invasion of brain microvascular endothelial cells. Infect. Immun. 64:146-153.
97. Quagliarelio, V. J., and W. M. Scheid. 1993 New perspectives on bacterial meningitis. Clin. Infect. Dis. 17:603-608.
98. Quagliarello, V. J., B. Wispelwey, W. J. Long, Jr., and W. M. Scheid. 1991. Recombinant human interleukm-l induces meningitis and blood-brain barrier injury in the rat. Characterization and comparison with tumor necrosis factor. J. Clin. Invest. 87:1360-1366.
99. Ramilo, O., M. M. Mustafa, J. Porter, X. Saez-Liorens, J. Mertsola, K. D. Olsen. J. P. Luby, B. Beutler, and G. H. McCracken, Jr. 1990. Detection of interleukin 1 beta but not tumor necrosis factor-alpha in cerebrospinal fluid of children with aseptic meningitis. Am. J. Dis. Child. 144:349-352.
100. Ramilo, O., M. M. Mustafa, X. Saez-Llorens, J. Mertsola, S. Ohkawara, M. Yoshinaga, E. J. Hansen, and G. H. McCracken, Jr, 1989. Role of interleukin 1-beta in meningeal inflammation. Pediatr. Infect. Dis. J. 8:909-910.
101. Ramilo, O., X. Saez-Llorens, J. Mertsola, H. Jafari. K. D. Olsen, E. J. Hansen, M. Yoshinaga, S. Ohkawara, H. Nariuchi, and G. H. McCracken, Jr. 1990. Tumor necrosis factor alpha/cachectin and interleukin 1 beta initiate meningeal inflammation. J. Exp, Med. 172:497-5117.
102. Remick, D. G., R. M. Stricter, J. P. Lynch III. D. Nguyen. M. Eskandari, and S. L. Kunkel, 1989. In vivo dynamics of murine tumor necrosis factoralpha gene expression. Kinetics of dexamethasone-induccd suppression. Lab. Invest. 60:766-771.
103. 100a. Rice, G. Personal communication.
104. Rice, G. C., P. A. Brown, R. J. Nelson, J. A. Bianco, J. W. Singer, and S. Burtsen. 1994. Protection from endotoxic shock in mice by pharmacologic inhibition of phosphatidic acid, Proc. Natl. Acad. Sci. USA 91:3857-3861.
105. Rlesenfeld-Orn, I., S. Wolpe, J. F. Garcia-Bustos, M. K. Hoffmann, and E. Tuomanen. 1989. Production of interleukin-l but not tumor necrosis factor by human monocytes stimulated with pneumococeal cell surface components. Infect. Immun. 57:1890-1893.
106. Roord, J. J., M. Apicella, and W. M. Scheld. 1994. The induction of meningeal inflammation and blood-brain harrier permeability by Haemophilus influenzae type b peptidoglycan. (Letter.) J. Infect. Dis. 170:254-256.
107. Sable, C. A., M. A. Aubin, and W. M. Scheid. 1991. Pentoxifylline (P) effect on Haemophilus influenzae type b (Hib)-induccd alteration in blood-brain barrier permeability (BBBP) in experimental meningitis, abstr. 920, p. 252. Program and Abstracts of the 31st Interscience Conference on Antimicrobial Agents and Chemotherapy, American Society for Microbiology, Washington. D.C.
108. Saez-Llorens, X., H. S. Jafari, C. Severlen, F. Parras, K. D. Olsen, E. J. Hansen, I. I. Singer, and G. H. McCracken, Jr, 1991. Enhanced attenuation of meningeal inflammation and brain edema by concomitant administration of anli-CD18 monoclonal antibodies and dexamethasone in experimental Haemophilus meningitis. J. Clin. Invest. 88:2003-2011.
109. Saez-Llorens, X., O. Ramilo, M. M. Mustafa, J. Mertsola. C. de Alba, E. Hansen, and G. H. McCracken. Jr. 1990. Pentoxifylline modulates meningeal inflammation in experimental bacterial meningitis. Antimicrob. Agents Chemother. 34:837-843.
110. Saez-Llorens, X., O. Ramilo, M. M. Mustafa, J. Mertsola, E. J. Hansen, and G. H. McCracken. Jr. 1989. Modulation of meningeal inflammation by treatment with pentoxifylline. Pediatr. Infect. Dis. J. 8:922-923.
111. Sampalo, E. P., E. N. Samo, R. Galilly, Z. A. Cohn, and G. Kaplan. 1991. Thalidomide selectively inhibits tumor necrosis factor α production by stimulated human monocytes. J. Exp. Med. 173:699-703.
112. Saukkonen, K., S. Sande, C. Cloffe, S. Wolpe, B. Sherry, A. Ceraml, and E. Tuomanen. 1990. The role of cytokines in the generation of inflammation and tissue damage in experimental gram-positive meningitis. J. Exp. Med. 171:439-448.
113. Schaad, U. B., U. Lips, H. E. Gnehm, A. Blumberg, I. Heinzer, and J. Wedgwood. 1993. Dexamethasone therapy for bacterial meningitis in children. Swiss Meningitis Study Group. Lancet 342:457-461.
114. Schandene, L. P. Vandenbussche, A. Cruslaux, M. L. Alegrr, D. Abramowicz, E. Dupont, J. Content, and M. Goldman. 1992. Differential effects of pentoxifylline on the production of tumour necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) by monocytes and T cells. Immunology 76:30-34.
115. Scheiman, R. I., P. C. Cogswell, A. K. Lofquist, and A. S. Baldwin. 1995. Role of transcriptional activation of IkBα in mediation of immunosuppression by glucocorlicoids. Science 270:283-290.
116. Scheid,W. M., V. J. Quagliarello, and B.Wispelwey. 1989. Potential role of host cytokines in Huemophilus influenzae lipopolysaccharide-induced blood-brain barrier permeability. Pediatr. Infect. Dis. J. 8:910-911.
117. Seitz, M., B. Dewald, N. Gerber, and M. Baggiolinl. 1991. Enhanced production of neutrophil-activating peptide-1/interleukin-8 in rheumatoid arthritis. J. Clin. Invest. 87:463-469.
118. Seki, T., K. Joh, and T. Oh-ishi. 1993. Augmented production of interleukin-8 in cerebrospinal fluid in bacterial meningitis. Immunology 80:333-335.
119. Selmaj, K. W., and C. S. Raine. 1988. Tumor necrosis factor mediates myclin and oligodendrocytc damage in vitro. Ann. Neurol. 23:339-346.
120. Semmier, J., U. Gebert, T. Eisenhut, J. Moeller, M. M. Schonharting, A. Allera, and S. Endres. 1993. Xanthine derivatives: comparison between suppression of tumour necrosis factor-alpha production and inhibition of cAM P phosphodiesterase activity. Immunology 78:5211-525.
121. Sharief, M. K., M. Clardi, and E. J. Thompson. 1992. Blood-brain barrier damage in patients with bacterial meningitis: association with tumor necrosis factor-alpha but not interleukin-1 beta. J. Infect. Dis. 166:3511-358.
122. Singer, J. W., S. L. Bursten, G. C. Rice, W. P. Gordon, and J. A. Blanco. 1994. Inhibitors of intracellular phosphatidic acid production: novel therapeutics with broad clinical applications, Exp. Opin. Invest. Drugs 3:631-643.
123. Stricter, R. M., D. G. Remick, P. A. Ward, R. N. Spengler, J. P. Lynch III, J. Larrick, and S. L. Kunkel. 1988. Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxifylline. Biochem. Biophys. Res. Commun. 155:1230-1236.
124. Sullivan, G. W., H. T. Carper, W. J. Novick, Jr., and G. L. Mandell. I988. Inhibition of the inflammatory action of interleukin-1 and tumor necrosis factor (alpha) on neutrophil function by pentoxifylline. Infect. Immun. 56:1722-1729.
125. Suschek, C., H. Rothe, K. Fehsel, J. Enczmann, and V. Kolb-Bachofen. 1993. Induction of a macrophage-like nitric oxide synthase in cultured rat aortic endotheliul cells. IL-1 beta-mediated induction regulated by tumor necrosis factor-alpha and IFN-gamma. J. Immunol. 151:3283-3291.
126. Syrogiannopoulos, G. A., E. J. Hansen, A. L. Erwin, R. S. Munford, J. Rutledge, J. S. Reisch, and G. H. McCracken, Jr. 1988. Haemophilus influenzae type b lipooligosaccharide induces meningeal inflammation J. Infect. Dis. 157:237-244.
127. Syroglannopoulos, G. A., K. D. Olsen, J. S. Reisch, and G. H. McCracken, Jr. 1987. Dexamethasone in the treatment of experimental Hacmophilus influenzae type b meningitis. J. Infect. Dis, 155:213-219.
128. Tang, T., P. S. Frenetic, R. O. Hynes, D. D. Wagner, and T. N. Mayadas. 1996. Cytokine-induccd meningitis is dramatically attenuated in mice deficient in endothelial selectins. J. Clin. Invest. 97:2485-2490.
129. I26. Tauber, M. G. 1989. Brain edema, intracrunial pressure and cerebral blood flow in bacterial meningitis. Pediatr. Infect. Dis. J. 8:915-917.
130. Tauber, M. G., U. Borschberg, and M. A. Sande. 1988. Influence of granulocytes on brain edema, intracranial pressure, and cerebrospinal fluid concentrations of lactate and protein in experimental meningitis. J. Infect. Dis. 157:456-464.
131. Tauber, M. G., H. Khayam-Bashi, and M. A. Sande. 1985. Effects of ampicillin and corticosteroids on brain water content, cerebrospinal fluid pressure, and cerebrospinal fluid lactate levels in experimental pneumococcal meningitis. J. Infect. Dis. 151:528-534.
132. Tauber, M. G., M. Sachdeva, S. L. Kennedy, H. Loetscher, and W. Lesslauer. 1992. Toxicity in neuronal cells caused by cerehrospinal fluid from pneumococcal and gram-negative meningitis. J. Infect. Dis. 166:1045-1050.
133. Tauber, M. G., A. M. Shibl, C. J. Hackbarth, J. W. Larrick, and M. A. Sande. 1987. Antibiotic therapy, endotoxin concentration in cerebrospinal fluid, and brain edema in experimental Escherichia coli meningitis in rabbits. J. Infect. Dis. 156:456-462.
134. Tauber, M. G., and A. Zwahlen. 1988. Animal models for meningitis, Methods Enzymol. 235:93-106.
135. Townsend, G. C., and W. M. Scheid. 1993. Adjunctive therapy for bacterial meningitis: rationale for use, current status, and prospects for the future. (Review.) Clin. Infect. Dis. 17(Suppl. 2):S537-S549.
136. Tsunawaki, S., M. Sporn, A. Ding, and C. Nathan. 1995. Deactivation of macrophages by transforming growth factor-β. Nature 334:260-262.
137. Tunkel, A. R., and W. M. Scheid. 1993. Pathogenesis and pathophysiology of bacterial meningitis. Clin. Microbiol. Rev. 6:118-136.
138. Tunkel, A. R., B. Wispelwey, V. J. Quagliarello, S. W. Rosser, A. J. Lesse, E. J. Hansen, and W. M. Scheid. 1992. Pathophysiology of blood-brain barrier alterations during experimental Haemophilus influenzae meningitis. J. Infect. Dis. 165(Suppl. 1):S119-S120.
139. Tuomanen, E., B. Hengstler, R. Rich, M. A. Bray, O. Zak, and A. Tomasz. 1987. Nonsteroidal anti-inflammatory agents in the therapy for experimental pneumococcal meningitis. J. Infect. Dis. 155:985-990.
140. Tuomanen, E., B. Hengstler, O. Zak, and A. Tomasz. 1986. Induction of mcningeal inflammation by diverse bacterial cell walls. Eur. J. Clin. Microbiul, 5:682-684.
141. Tuomanen, E., H. Liu, B. Hengstler, O. Zak, and A. Tomasz. 1985. The induction of meningeal inflammation by components of the pneumococcal cell wall. J. Infect. Dis. 151:859-868.
142. Tuomanen, E., A. Tomasz, B. Hengstler, and O. Zak. 1985. The relative role of bacterial cell wall and capsule in the induction of inflammation in pneumococcal meningitis. J. Infect. Dis. 151:535-540.
143. Tuomanen, E. l., K. Saukkonen, S. Sande, C. Cloffe, and S. D. Wright. 1989. Reduction of inflammation, tissue damage, and mortality in bacterial meningitis in rabbits treated with monoclonal antibodies against adhesionpromoting receptors of leukocytes. J. Exp. Med. 170:959-969.
144. Tureen, J. 1995. Effect of recombinant human tumor necrosis factor-alpha on cerebral oxygen uptake, cerebrospinal fluid lactate, and cerebral blood flow in the rabbit: role of nitric oxide. J. Clin. Invest. 95:1086-1091.
145. Tureen, J. H., M. G. Tauber, and M. A. Sande. 1991. Effect of indomethacin on the pathoptiysiology of experimental meningitis in rabbits. J. Infect. Dis. 163:647-649.
146. Tureen, J. H., M. G. Tauber, and M. A. Sande. 1992. Effect of hydration status on cerebral blood flow and cerebrospinal fluid lactic acidosis in rabbits with experimental meningitis. J. Clin. Invest. 89:947-953.
147. van der Poll, T., J. Jansen, M. Levi H. ten Gate, J. W. ten Cate, and S. J. van Deventer. 1994. Regulation of interleukin 10 release by tumor necrosis factor in humans and chimpanzees. J. Exp. Med. 180:1985-1988.
148. van Furth, A. M., E. M. Seijmonsbergen, P. H. P. Groeneveld, R. Van Furth, and J. A. M. Langermans. 1996. Levels of nitric oxide correlate with high levels of tumor necrosis factor-α in cerebrospinal fluid samples from children with bacterial meningitis. Clin. Infect. Dis. 22:876-878.
149. van Furth, A. M., E. M. Seijmonsbergen, J. A. M. Langermans, P. H. P. Groeneveld, C. E. De Bel, and R. Van Furth. 1995. High levels of interleukin 10 and tumor necrosis factor a in cerebrospinal fluid during the onset of bacterial meningitis. Clin. Infect. Dis. 21:220-222.
150. van Furth, A. M., E. M. Seijmonsljergen, J. A. M. Langermans, P. H. P. Van der Melde, and R. Van Furth. 1995. Effect of xanthine derivates and dexamethasone on Streptococcus pneumoniae-slimulated production of tumor necrosis factor alpha, interleukin Iβ (IL-Iβ) and IL-10 by human leukocytes. Clin. Diagn. Lab. Immunol. 2:689-692.
151. van Furth, A. M., E. M. Seijmonsbergen, R. Van Furth, and J. A. M. Langermans. 1996. Effect of lisofylline and pentoxifylline on the bacterial-stimulated production of TNF-α, IL-I β and IL-10 by human leukocytes. Submitted for publication.
152. van Furth, A. M., T. M. Steenwijk, J. A. Langermans, and R. Van Furth. 1994. In vitro effect of dexamethasone, pentoxifylline, and anti-endotoxin monoclonal antibody on the release of proinflammatory mediators by human leukocytes stimulated with Haemophilus influenzas type b. Pediatr. Res. 35:725-728.
153. Van Meir, E., M. Ceska, F. Effenberger, A. Waiz, E. Grouzmann, I. Desbaillets, K. Frei, A. Fontana, and N. de Tribolet. 1992. lnterleukin-8 is produced in neoplastic and infectious diseases of the human central nervous system. Cancer Res. 52:4297-4305.
154. Van Snick, J. 1990. Interlcukin-6: an overview. Annu. Rev. Immunol. 8: 253-278.
155. Vaporcivan, A., B. K. Bonish, and P. A. Ward. 1994. In vivo and in vitro regulation of ICAM-1 and MCP-1 expression by interleukin-10 (IL-10), FASEB J. 8:A266.
156. Visser, J. J., R. J. Scholten, and K. Hoekman. 1994. Nitric oxide synthesis in meningococcal meningitis. Ann. Intern. Med. 120:345-346.
157. Waage, A., and O. Bakke. 1988. Glucocorticoids suppress the production of tumour necrosis factor by lipopolysaccharide-stimulated human monocytes. Immunology 63:299-302.
158. Waage, A., A. Halstensen, and T. Espevik. 1987. Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet 1:355-357.
159. Waage, A., A. Halstensen, R. Shalaby, P. Brandtzaeg, P. Klerulf, and T. Espevik. 1989. Local production of tumor necrosis factor alpha, inturleukin 1, and interleukin 6 in meningococcal meningitis. Relation to the inflammatory response. J. Exp. Med. 170:1859-1867.
160. Waage, A., M. Sorensen, and B. Stordal. 1990. Differential effect of oxpentirylline on tumour necrosis factor and interleukin-6 production. Lancet 335:543.
161. Wahl, S. M., D. A. Hunt, L. M. Wakefield, N. McCartney-Francis, L. M. Wahl, A. B. Roberts, and M. B. Sporn. 1987. Transforming growth factor β induces monocyte chemotaxis and growth factor production. Proc. Natl. Acad. Sci. USA 84:5788-5792.
162. Wahl, S. M., N. McCartney-Francis, and S. E. Mergenhagen. 1989. Inflammatory and immunomodulatory roles of TGF-β, Immunol. Today 10:258-261.
163. Wald, E. R., S. L. Kaplan, E. O. Mason, D. Sabo, L. Ross, A. Arditi, B. L. Wiedermann, W. Barson, K. S. Kim, R. Yogev, and D. Hofkosh. 1995. Dexamethasone therapy for children with bacterial meningitis. Pediatrics 95:21-28.
164. Wang, P., P. Wu, M. I. Siegel, R. W. Egan, and M. M. Billah. 1994. IL-10 inhibits transcription of cytokine genes in human peripheral blood mononuclear cells. J. Immunol. 153:811-816.
165. Wanidworanun, C. and W. Strober. 1993. Predominant role of tumor necrosis factor-alpha in human monocyte IL-10 synthesis. J. Immunol. 151:6853-6861.
166. Wispelwey, B., E. J. Hansen, A. Lesse, and W. M. Scheid. 1989. Haemophilus influenzae virulence factors in experimental meningitis. Pediatr. Infect. Dis. J. 8:903-904.
167. Xie, Q., and C. Nathan, 1994. The high-output nitric oxide pathway: role and regulation. J. Leukocyte Biol. 56:576-582.
168. Zabel, P., D. T. Wolter, M. M. Schonharting, and U. F. Schade. 1989. Oxpentifylline in endotoxaemia. Lancet 11:1474-1477.